Clinical Trial Update: EXCimEr Laser for Long lENgTh Lesions in Below-The-Knee Arteries Study [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial of the EXCimEr Laser for long lesions in below-the-knee arteries for peripheral artery disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Snippet

Sponsor: Flanders Medical Research Program | Conditions: Peripheral Arterial Occlusive Disease | Phase 2, Phase 3 | Status: TERMINATED